Clin2
NCT06512233Possibly a fitNot yet recruiting

Heparin vs Heparin-Aspirin for Free Flap Success

Complication,Postoperative

Part of Heart & circulation clinical trials.

This trial compares using heparin alone versus heparin plus aspirin to improve survival of free flap surgeries. It may help if you are having this type of reconstructive surgery and are not at high risk for bleeding or allergic reactions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
126 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are scheduled for free flap surgery (reconstructive surgery where tissue is moved from one part of your body to another).
  • You are between 18 and 70 years old.
  • No known allergies to heparin or aspirin, and no history of bleeding disorders.
  • You are not taking other blood thinners (like warfarin, clopidogrel, or rivaroxaban).
  • No severe kidney or liver disease.
  • If you take aspirin, you can safely stop it 5 days before surgery (without high risk of heart problems).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06096116Recruiting· Phase 3
Trial of a blood product for heparin resistance during heart surgery

This study tests a blood-derived medicine (antithrombin) to help people who do not respond well to the blood thinner heparin during heart surgery. It aims to make surgery safer by improving blood thinning.

Stanford, California
NCT03244020Enrolling by invitation· Phase 4
Aspirin or low-dose blood thinner after bone or leg surgery

This trial compares aspirin versus a low-dose injectable blood thinner (LMWH) to prevent blood clots after certain orthopedic cancer surgeries. It may help lower the risk of dangerous clotting while balancing bleeding and side effects.

Los Angeles, California
NCT03302195Recruiting
Heparin and bypass blood management for obese heart surgery

This trial studies the best way to manage blood thinning (anticoagulation) during heart surgery that uses a heart-lung machine in people with obesity. It may help reduce blood-clotting and bleeding complications by comparing different care strategies.

Québec, Quebec
NCT07549568Not yet recruiting
Antithrombin levels and blood thinning response in heart surgery

This study looks at whether a protein called antithrombin can predict how well a blood thinner called heparin will work during heart surgery. Understanding this connection may help doctors better manage blood clotting during your operation.

Gothenburg, Västra Götalandsregionen
NCT04374799Recruiting· Phase 3
Heparin vs placebo during cardiac catheterization

This trial tests whether giving heparin (a blood thinner) during a specific type of heart procedure is safer and works better than not giving it. It focuses on patients where the blood supply in the hand’s artery connection is functioning properly.

Hamilton, Ontario
NCT05209841Recruiting
Heparin versus saline to keep IV line working

This trial compares using heparin (a blood-thinning medicine) versus saline (salt water) to keep a peripheral IV line open and working. It may help reduce line blockage and improve how well IV treatments can be given.

Sant Pere de Ribes, Barcelona

Hear when a new Complication,Postoperative trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.